Contact us

Screen

Automatic analysis tool for ligand screening NMR data

Mnova Screen is a simple, efficient tool with flexible analysis and reporting features, trusted by top pharmaceutical companies. It handles data from various screening experiments, including 1H or 19F, single compounds or mixtures, with or without reference spectra, and multiple spectra types.


Download Mnova for a 45-Day Free Trial of Mnova Screen

Screen

Benefits

Pattern recognition algorithms map your experimental data.

Considers the use of STD, wLOGSY, T1rho, CMPG experiments.

Uses deconvolution to effectively pick peak even weak signals.

Result viewer to quickly inspect your hits.

Export metrics of your analysis into your favorite statistical package.

Screen

Features

Handles all kinds of screening data

Mnova Screen gives a great versatility in the choice of screening experiments

Data Organization for batch processing

Ability to read Bruker FBS output (master data file) for seamless data input exchange

19F Automatic hit detection based on intensity changes

Results of 19F screening of a mixture of 20 ligands (top) using the CPMG experiments of ligands without protein (bottom), ligands with protein (second bottom), and ligands with protein and inhibitor (3rd bottom)

Latest Screen news

Optimizing Fragment-Based Drug Discovery by NMR: A Deep Dive into Mnova Screening Software Solutions

Fragment-Based Drug Discovery (FBDD) and validation of small molecules binders using NMR has emerged as a powerful method in early-stage drug development. This post explores the general use of analytical techniques and innovative screening software solutions that optimize the process, enabling researchers to identify promising drug candidates with precision.

Read more
Webinar-recording-FBDD

Fragment-Based Drug Discovery (FBDD) Application | Webinar

Dr. Andrew “Dru” Namanja, Principal Research Scientist at AbbVie, will explore the potency ranking methods involving both qualitative single-point ligand concentration (Q Score) and quantitative binding affinity (KD), and how the combined utility can be used successfully to drive a Fragment-Based Drug Discovery (FBDD) campaign

Read more
Screen

Related Applications

Academic, Government & Industrial

Target Audience

Medicinal Chemists​
Analytical Chemists​
Biochemists​
Screen

Case Studies

novartis-case-study

A successful collaboration with Novartis on automated analysis of ligand-observed 1H-19F NMR binding data for fragment based lead generation

Several groups in Novartis use NMR binding assays to find and validate hits during the early stages of drug discovery. They use ligand-observed NMR experiments such as STD, T1ρ, and CPMG to identify library compounds that interact with a target protein.

Read more
Screen

Related Products

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.